Show Summaries | Hide Summaries
We currently have no Breaking News on this stock.
VCEL vs. ETF Alternatives
Vericel Corpis engaged in the development of patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions. It markets two cell therapy products including Carticel and Epicel.
Other News & PR